Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
dc.contributor.author | Baden, Lindsey R | |
dc.contributor.author | El Sahly, Hana M | |
dc.contributor.author | Essink, Brandon | |
dc.contributor.author | Follmann, Dean | |
dc.contributor.author | Neuzil, Kathleen M | |
dc.contributor.author | August, Allison | |
dc.contributor.author | Clouting, Heather | |
dc.contributor.author | Fortier, Gabrielle | |
dc.contributor.author | Deng, Weiping | |
dc.contributor.author | Han, Shu | |
dc.contributor.author | Zhao, Xiaoping | |
dc.contributor.author | Leav, Brett | |
dc.contributor.author | Talarico, Carla | |
dc.contributor.author | Girard, Bethany | |
dc.contributor.author | Paila, Yamuna D | |
dc.contributor.author | Tomassini, Joanne E | |
dc.contributor.author | Schödel, Florian | |
dc.contributor.author | Pajon, Rolando | |
dc.contributor.author | Zhou, Honghong | |
dc.contributor.author | Das, Rituparna | |
dc.contributor.author | Miller, Jacqueline | |
dc.date.accessioned | 2021-11-30T18:43:37Z | |
dc.date.available | 2021-11-30T18:43:37Z | |
dc.date.issued | 2021-11-03 | |
dc.identifier.uri | http://hdl.handle.net/10713/17223 | |
dc.description.uri | https://doi.org/10.1056/NEJMc2115597 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Massachusetts Medical Society | en_US |
dc.relation.ispartof | New England Journal of Medicine | en_US |
dc.subject | Coronavirus Efficacy trial (COVE) | en_US |
dc.subject | delta variant | en_US |
dc.subject | mRNA-1273 | en_US |
dc.subject.mesh | COVID-19 Vaccines | en_US |
dc.title | Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1056/NEJMc2115597 | |
dc.identifier.pmid | 34731553 | |
dc.source.country | United States |